SEMA3A and prostate cancer: Inhibition of HIF-1α suppressed prostate cancer, Evodiamine impairs HIF-1α histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing prostate cancer cell ferroptosis 19.